Log in to save to my catalogue

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental pe...

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental pe...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f3d564453a3a45699eab302dd28bf0ec

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy

About this item

Full title

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy

Publisher

England: John Wiley & Sons, Inc

Journal title

ESC Heart Failure, 2021-08, Vol.8 (4), p.3375-3381

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Aims
Peripartum cardiomyopathy (PPCM) is a pregnancy‐associated cardiomyopathy that occurs in previously heart‐healthy women towards the end of pregnancy or in the first months after delivery and is characterized by heart failure due to systolic dysfunction. The clinical course of PPCM differs between mild symptoms and severe forms with acute he...

Alternative Titles

Full title

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f3d564453a3a45699eab302dd28bf0ec

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f3d564453a3a45699eab302dd28bf0ec

Other Identifiers

ISSN

2055-5822

E-ISSN

2055-5822

DOI

10.1002/ehf2.13412

How to access this item